- Home
- CRBP vs PETS Comparison
CRBP vs PETS Comparison
Compare CRBP & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- PETS
- Stock Information
- Founded
- CRBP 2009
- PETS 1996
- Country
- CRBP United States
- PETS United States
- Employees
- CRBP N/A
- PETS N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- CRBP Health Care
- PETS Consumer Staples
- Exchange
- CRBP Nasdaq
- PETS Nasdaq
- Market Cap
- CRBP 73.4M
- PETS 62.8M
- IPO Year
- CRBP N/A
- PETS N/A
- Fundamental
- Price
- CRBP $6.65
- PETS $3.58
- Analyst Decision
- CRBP Strong Buy
- PETS Sell
- Analyst Count
- CRBP 10
- PETS 2
- Target Price
- CRBP $53.56
- PETS $3.35
- AVG Volume (30 Days)
- CRBP 148.0K
- PETS 146.6K
- Earning Date
- CRBP 05-06-2025
- PETS 06-10-2025
- Dividend Yield
- CRBP N/A
- PETS N/A
- EPS Growth
- CRBP N/A
- PETS N/A
- EPS
- CRBP N/A
- PETS 0.02
- Revenue
- CRBP N/A
- PETS $247,010,000.00
- Revenue This Year
- CRBP N/A
- PETS N/A
- Revenue Next Year
- CRBP $150.00
- PETS N/A
- P/E Ratio
- CRBP N/A
- PETS $212.14
- Revenue Growth
- CRBP N/A
- PETS N/A
- 52 Week Low
- CRBP $4.64
- PETS $2.90
- 52 Week High
- CRBP $61.90
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- CRBP 48.86
- PETS 51.99
- Support Level
- CRBP $6.10
- PETS $3.26
- Resistance Level
- CRBP $8.07
- PETS $3.70
- Average True Range (ATR)
- CRBP 0.70
- PETS 0.15
- MACD
- CRBP -0.07
- PETS 0.07
- Stochastic Oscillator
- CRBP 26.50
- PETS 75.38
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.